List of insiders holdings for XOMA LTD:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | 14159 capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2015-07-23 17:27:50 | 6,192,811 0 |
6,192,811 | Form 13D |
2 | Baker Brothers Life Sciences Capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2015-07-23 17:27:50 | 6,192,811 0 |
6,192,811 | Form 13D |
3 | Baker Biotech Capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2015-07-23 17:27:50 | 6,192,811 0 |
6,192,811 | Form 13D |
4 | Klein Thomas Chief Commercial Officer |
2015-03-20 19:30:35 | 347,679 4,660 |
352,339 | Form 4 |
5 | RUBIN PAUL D Sr. VP Clinical Dev. & CMO |
2016-03-22 21:01:31 | 326,601 13,422 |
340,023 | Form 4 |
6 | Hughes Owen Chief Executive Officer |
2024-11-13 18:55:07 | 258,619 0 |
258,619 | Form 4 |
7 | Neal James R CEO |
2022-07-18 16:30:18 | 229,878 21,560 |
251,438 | Form 4 |
8 | CASTELLO JOHN L President, CEO and |
2008-02-11 18:42:02 | 128,670 65,803 |
194,473 | Form 5 |
9 | DAVIS PETER B VP, Finance & CFO |
2005-03-17 21:00:10 | 15,589 151,210 |
166,799 | Form 4 |
10 | DELLIO CLARENCE L Sr VP, Operations and COO |
2005-05-12 13:49:15 | 101,456 15,976 |
117,432 | Form 4 |
11 | KURLAND FRED CFO & VP Finance |
2015-04-07 19:20:48 | 75,461 27,391 |
102,852 | Form 4 |
12 | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP 14159 L.P. Baker Bros. Advisors (GP) LLC BAKER FELIX BAKER JULIAN Former 10% owner |
2015-07-23 17:35:06 | 0 90,538 |
90,538 | Form 4 |
13 | BOWES WILLIAM K JR Director |
2015-06-01 18:24:53 | 82,139 1000 |
83,139 | Form 4 |
14 | BOYLE J DAVID II VP, Finance, and CFO |
2008-05-14 18:36:20 | 80,000 0 |
80,000 | Form 4/A |
15 | DATTA DEEPSHIKHA Chief Business Officer |
2019-02-15 17:01:15 | 50,000 0 |
50,000 | Form 4 |
16 | Neu Kelvin Director |
2012-07-23 17:04:04 | 40,000 0 |
40,000 | Form 4 |
17 | ANDRESS JAMES G Director |
2008-05-14 18:32:36 | 33,500 0 |
33,500 | Form 4/A |
18 | MARGOLIN CHRISTOPHER J VP, General Counsel & Sec'y |
2012-02-14 16:55:29 | 5,048 25,377 |
30,425 | Form 5 |
19 | BURNS THOMAS M. SVP, Finance & CFO |
2025-04-02 16:30:24 | 19,272 6,130 |
25,402 | Form 4 |
20 | Sitko Bradley Chief Investment Officer |
2025-04-09 16:44:30 | 16,842 4,561 |
21,403 | Form 4 |
21 | KORNBERG ARTHUR MD Director |
2007-08-27 17:49:45 | 0 20,000 |
20,000 | Form 4/A |
22 | PERRY MATTHEW D See Explanation of Responses |
2024-05-17 16:30:45 | 17,869 0 |
17,869 | Form 4 |
23 | LIMBER JOSEPH M Director |
2025-04-07 16:39:59 | 16,208 0 |
16,208 | Form 4 |
24 | WYSZOMIERSKI JACK L Director |
2024-05-17 16:30:53 | 12,533 0 |
12,533 | Form 4 |
25 | FISHER CHARLES J JR Director |
2011-01-11 17:02:00 | 11,850 0 |
11,850 | Form 4 |
26 | SCANNON PATRICK J MD PHD Exec. VP & CSO |
2016-12-23 18:36:11 | 8,217 1,929 |
10,146 | Form 4 |
27 | MENDELL STEVEN C Director |
2004-05-20 19:56:11 | 10,000 0 |
10,000 | Form 4 |
28 | Franklin Heather L Director |
2024-05-17 16:30:28 | 9,763 0 |
9,763 | Form 4 |
29 | Kosacz Barbara Director |
2024-05-17 16:30:38 | 9,763 0 |
9,763 | Form 4 |
30 | VAN NESS W DENMAN Director |
2022-05-20 09:00:25 | 8,996 0 |
8,996 | Form 4 |
31 | HUTT PETER BARTON Director |
2017-05-22 18:38:51 | 8,000 0 |
8,000 | Form 4 |
32 | Varian John Director |
2017-05-22 18:43:13 | 8,000 0 |
8,000 | Form 4 |
33 | Walbert Timothy P Director |
2017-05-22 18:45:29 | 8,000 0 |
8,000 | Form 4 |
34 | Hernday Natasha Director |
2024-05-17 16:30:35 | 7,916 0 |
7,916 | Form 4 |
35 | ENGLE STEVEN B Chairman, CEO & President |
2011-02-11 13:54:53 | 0 6,866 |
6,866 | Form 5 |
36 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
2025-01-28 17:23:33 | 4,231 772 |
5,003 | Form 4 |
37 | ZENNER PATRICK J Director |
2010-07-26 16:12:51 | 0 0 |
0 | Form 4 |